Nick Keher is BenevolentAI’s Chief Financial Officer and is responsible for all financial activities of the Company as well as investor relations.
Nick has 15 years of experience in the pharma and biotech industry. Prior to joining BenevolentAI, he was CFO of Clinigen, a UK AIM-listed global pharmaceutical and pharma services company with over £450 million of revenue that was acquired by Triton PE for £1.3 billion.
Nick previously spent eight years as a top-rated analyst covering the healthcare sector, initially at the investment bank Investec and then Royal Bank of Canada, where he was Managing Director and Head of the Healthcare Equity Research desk for Europe, building its healthcare equity research Platform. As an analyst, Nick advised leading UK, US and EU institutional funds on investment decisions whilst also helping companies raise over £2.5 billion of capital across various IPOs and equity raises to execute on growth plans, all within the healthcare space. Now as CFO, he has gone from reviewing companies and their strategies to enacting them.
He started his career as a pharmacist before moving to global biopharma GlaxoSmithKline where he completed his CIMA accountancy qualification working within R&D, pharma and global manufacturing and supply strategy.